+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Synthon Holdings BV - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 23 Pages
  • April 2020
  • GlobalData
  • ID: 3512856
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Synthon Holdings BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – The publisher's summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina, South Korea and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Synthon Holdings BV - Key Facts
  • Synthon Holdings BV - Key Employees
  • Synthon Holdings BV - Major Products and Services
  • Synthon Holdings BV - History
  • Synthon Holdings BV - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 – Company Analysis
  • Company Overview
  • Synthon Holdings BV - Business Description
  • Synthon Holdings BV - SWOT Analysis
  • SWOT Analysis - Overview
  • Synthon Holdings BV - Strengths
  • Synthon Holdings BV - Weaknesses
  • Synthon Holdings BV - Opportunities
  • Synthon Holdings BV - Threats
  • Synthon Holdings BV - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • Synthon Holdings BV, Recent Deals Summary

Section 4 – Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • Synthon Holdings BV, Key Facts
  • Synthon Holdings BV, Key Employees
  • Synthon Holdings BV, Major Products and Services
  • Synthon Holdings BV, History
  • Synthon Holdings BV, Subsidiaries
  • Synthon Holdings BV, Key Competitors
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • Synthon Holdings BV, Recent Deals Summary

List of Figures
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Ranbaxy Netherlands BV
  • Truvion Healthcare BV
  • Nexins Research BV
  • Disphar International BV
  • Zentiva NV